These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24406136

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance.
    Liu BJ, Xu QY, Yu WD, Li N, Yao T, Zhao LJ, Wang JL, Wei LH, Li XP.
    Front Med (Lausanne); 2020; 7():70. PubMed ID: 32258043
    [Abstract] [Full Text] [Related]

  • 4. [Establishment of cisplatin-resistant human endometrial cancer cell line and the study of its resistant mechanisms].
    Xu QY, Chen YH, Zhao LJ, Li XP, Wang JL, Wei LH.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):533-7. PubMed ID: 22041447
    [Abstract] [Full Text] [Related]

  • 5. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
    Zhao SJ, Chen XJ, Feng YJ.
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr; 40(2):103-12. PubMed ID: 17580663
    [Abstract] [Full Text] [Related]

  • 6. Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells.
    Alkhalaf M, Murphy LJ, Murphy LC.
    Mol Endocrinol; 1993 Dec; 7(12):1634-41. PubMed ID: 8145769
    [Abstract] [Full Text] [Related]

  • 7. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS, Qamar L, Behbakht K, Post MD, Sheeder J, Sartorius CA, Spillman MA.
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [Abstract] [Full Text] [Related]

  • 8. [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
    Jin Y, Feng CP, Wang YN, Lin H, Li HJ, Pan XY.
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):368-72. PubMed ID: 22883527
    [Abstract] [Full Text] [Related]

  • 9. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
    Cao W, Gao W, Zheng P, Sun X, Wang L.
    BMC Med Genomics; 2019 Nov 12; 12(1):163. PubMed ID: 31718641
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ.
    Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr 15; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
    Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T, Umeda M.
    Oral Oncol; 2011 Sep 15; 47(9):855-60. PubMed ID: 21757396
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y, Tong J, Ai Z, Wang J, Teng Y.
    J Obstet Gynaecol Res; 2012 Dec 15; 38(12):1358-66. PubMed ID: 22612393
    [Abstract] [Full Text] [Related]

  • 14. Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.
    Li XX, Wang J, Wang HL, Wang W, Yin XB, Li QW, Chen YY, Yi J.
    Biochem Biophys Res Commun; 2012 Mar 23; 419(4):728-34. PubMed ID: 22387537
    [Abstract] [Full Text] [Related]

  • 15. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
    Shishido Y, Ueno S, Yamazaki R, Nagaoka M, Matsuzaki T.
    Anticancer Res; 2013 Apr 23; 33(4):1379-86. PubMed ID: 23564776
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
    Nakamura M, Zhang X, Mizumoto Y, Maida Y, Bono Y, Takakura M, Kyo S.
    Int J Oncol; 2014 Mar 23; 44(3):669-77. PubMed ID: 24366104
    [Abstract] [Full Text] [Related]

  • 17. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24.
    Ning ZF, Huang YJ, Lin TX, Zhou YX, Jiang C, Xu KW, Huang H, Yin XB, Huang J.
    J Int Med Res; 2009 Mar 23; 37(3):621-30. PubMed ID: 19589244
    [Abstract] [Full Text] [Related]

  • 18. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
    Zhang QH, Dou HT, Xu P, Zhuang SC, Liu PS.
    Drug Res (Stuttg); 2015 Mar 23; 65(3):153-7. PubMed ID: 25504004
    [Abstract] [Full Text] [Related]

  • 19. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
    Hu Q, Yu L, Chen R, Wang YL, Ji L, Zhang Y, Xie Y, Liao QP.
    Int J Gynecol Cancer; 2012 Jul 23; 22(6):951-9. PubMed ID: 22683940
    [Abstract] [Full Text] [Related]

  • 20. ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.
    Shan W, Wang C, Zhang Z, Luo X, Ning C, Yu Y, Feng Y, Gu C, Chen X.
    Tumour Biol; 2015 Mar 23; 36(3):1529-37. PubMed ID: 25608836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.